Author:
Caminati M.,Cegolon L.,Bacchini M.,Segala N.,Dama A.,Bovo C.,Olivieri B.,Furci F.,Senna G.
Abstract
Abstract
Background
Asthma control and monitoring still represents a challenge worldwide. Although the international guidelines suggest the interplay between secondary and primary care services as an effective strategy to control the disease, community pharmacies’ are seldom involved in asthma control assessment.
The present cross-sectional study aimed at providing a picture of the relationship between asthma severity and control in community pharmacies within the health district of the city of Verona (Veneto Region, North-Eastern Italy).
Methods
A call for participation was launched through the Pharmacists’ Association of Verona. Patients referring to the participating pharmacies with an anti-asthmatic drug medical prescription and an asthma exemption code were asked to complete the Asthma Control Test (ACT) and a brief questionnaire collecting information on their age, sex, smoking status, aerobic physical exercise and usual asthma therapy, which also defined asthma severity. A multinomial logistic regression model was fitted to investigate the risk of uncontrolled as well as poorly controlled vs. controlled asthma (base). Results were expressed as relative risk ratios (RRR) with 95% confidence interval (95%CI).
Results
Fifty-seven community pharmacies accepted to participate and 584 asthmatic patients (54% females; mean-age: 51 ± 19 years) were consecutively recruited from 1st January to 30th June 2018 (6 months). Based upon ACT score 50.5% patients had a controlled asthma, 22.3% a poorly controlled and 27.2% uncontrolled. A variable proportion of patients with uncontrolled asthma were observed for every level of severity, although more frequently with mild persistent form of asthma. Most patients (92%) self-reported regular compliance with therapy. At multinomial regression analysis, patients under regular asthma treatment course (RRR = 0.33; 95%CI: 0.15; 0.77) were less likely to have an ACT< 16 compared to those not taking medications regularly.
Conclusions
Overall, our findings highlighted an unsatisfactory asthma control in the general population, independently of the severity level of the disease. Community pharmacies could be a useful frontline interface between patients and the health care services, supporting an effective asthma management plan, from disease assessment and monitoring treatment compliance to referral of patients to specialist medical consultancies.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference34 articles.
1. Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, Krass I, Saini B, Smith L, Stewart K. Pharmacy asthma care program (PACP) improves outcomes for patients in the community. Thorax. 2007;62:496–502.
2. Bousquet J, Bousquet PJ, Godard P, et al. The public health implications of asthma. Bull WHO. 2005;83:548–54.
3. Wijnant SRA, Lahousse L, De Buyzere ML, Brusselle GG, Rietzschel ER. Prevalence of asthma and COPD and blood eosinophil count in a middle-aged Belgian population. J Clin Med. 2019;8(8):1122.
4. Australian Centre for Asthma Monitoring. Health care expenditure and the burden of disease due to asthma in Australia. Canberra: Australian Institute of Health and Welfare; 2005. p. 43.
5. Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, et al. Asthma control in Europe. A real world evaluation based on an international population-based study. J Allergy Clin Immunol. 2007;120:1360–7.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献